European Scientific Working group on Influenza

What European Scientific Working group on Influenza does

European Scientific Working Group on Influenza (ESWI) is a Brussels-headquartered, Belgium-registered non-profit scientific coordination body founded in 1993. Its stated mission is to reduce the burden of major acute respiratory virus infections — including influenza, COVID-19, RSV, and hMPV — by fostering stakeholder communication and cross-disciplinary research in Europe. ESWI does not develop or sell proprietary technology products; its core assets are an expert network (100+ named scientists on its expert database, including Board Members, Associate Members, and affiliated researchers), a coalition of 25+ partner organisations across Europe and globally, and a portfolio of convening and content platforms.

ESWI's product portfolio consists of nine named services across three categories: (1) event services including the biennial ESWI Conferences (the largest European scientific conference dedicated to influenza and other acute respiratory viruses), the off-cycle Respiratory Virus Summits (featuring the Science and Policy Interface event), and the annual Science Policy Interface Roundtables held in EU Member States; (2) educational content including the Education Hub (a curated repository of articles, scientific papers, and FAQs reviewed by Board Members), the ESWI Airborne Podcast series, scientific webinars, and the Viral Times newsletter; and (3) internal networks including the Interdisciplinary Disease Collaboration (linking respiratory infections with non-communicable diseases) and the Early Career Scientists' Network. The Brussels secretariat at Rue de la Loi 155 manages operations, and ESWI is registered in the EU Transparency Register.

ESWI's business model is structured as a non-profit scientific society rather than a commercial enterprise. Revenue streams consist of conference and event income (registration fees, sponsorships, exhibitor participation) and financial supporter contributions alongside likely grant funding; the organisation maintains an EU Transparency Register entry. Primary customer segments are policymakers and government health authorities, scientists and researchers in influenza and respiratory viruses, healthcare professionals and clinicians, the general public (including high-risk groups), and stakeholder organisations/coalition partners. Distribution is hybrid: in-person attendance at conferences, summits, and roundtables in conjunction with digital access to the Education Hub, podcasts, and webinars, amplified through the coalition partner network across Europe, Asia Pacific, the Middle East/Africa, and the Americas.

Name

European Scientific Working group on Influenza

Legal name

ESWI (European Scientific Working Group on Influenza)

Website

https://eswi.org

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

1–10 employees

Short description

ESWI is a Brussels-based non-profit scientific working group, founded in 1993, that reduces the burden of major acute respiratory virus infections by convening scientists, policymakers, healthcare professionals, and 25+ coalition partners through biennial conferences, summits, roundtables, and a curated Education Hub.

Ownership category

akta.pro rank

Headquarters

HQ city

Brussels

HQ country

Belgium

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Conference and event revenue: ESWI organises major biennial conferences and summits which generate revenue through registration fees, sponsorships, and exhibitor participation.
2. Financial supporters and grants: ESWI draws upon several resources including financial supporters and likely grant funding to finance its activities and plans, as stated on its website. The organisation has a transparency register entry with the European Union.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels8 records

Core offering

ESWI is a scientific working group that organises biennial influenza conferences, annual Respiratory Virus Summits with Science and Policy Interface events, and annual Science Policy Interface Roundtables in EU Member States. It additionally produces the Airborne Podcast series, year-round scientific webinars, and maintains the ESWI Education Hub — a digital repository of peer-reviewed articles, FAQs, and scientific papers. The organisation coordinates two standing networks (IDC and ECaS) and convenes a coalition of 25+ partner organisations and 100+ experts focused on influenza, COVID-19, RSV, and hMPV.

Product overview

ESWI is a European scientific network focused on reducing the burden of major acute respiratory virus infections by fostering stakeholder communication and cross-disciplinary research. Rather than a unified software product, ESWI operates as a coalition of educational and networking services including the ESWI Airborne Podcast series, ESWI Education Hub (a content repository), ESWI Conferences (biennial scientific conferences), ESWI Respiratory Virus Summits, Science Policy Interface Roundtables, ESWI Webinars, and professional networks (IDC and ECaS). The organization connects scientists, policymakers, healthcare professionals, and patient organizations through events, educational content, and collaborative networks.

Differentiator

Problem solved

Functional benefit

Products and services

• ESWI Conferences The largest European scientific conference dedicated to influenza and other acute respiratory virus diseases, including COVID-19, RSV and hMPV, organised every two years for scientists, clinicians, policymakers, and industry stakeholders.
• ESWI Respiratory Virus Summits Summit held in non-conference years featuring a tailored Science and Policy Interface event where policymakers and scientific experts collaborate to advance evidence-based public health policies on respiratory virus infections.
• Science Policy Interface Roundtables Annual roundtables organised in EU Member States bringing together national policymakers, scientists, and journalists to facilitate dialogue aimed at improving influenza prevention, control, and vaccine uptake.
• ESWI Webinars Year-round scientific webinars featuring distinguished guests and experts discussing current developments in influenza and other acute respiratory viral diseases.
• ESWI Airborne Podcast Podcast series managed by the ESWI Secretariat and hosted by an experienced writer and editor, featuring discussions on influenza and other acute respiratory viral diseases, intervention strategies, and expert interviews.
• ESWI Education Hub Online platform providing articles, scientific papers reviewed by ESWI Board Members, and educational content on topics including Avian Influenza, H5N1, COVID-19, RSV, vaccines, prevention, and epidemiology, including FAQs addressed to the general public.
• Interdisciplinary Disease Collaboration (IDC) Network uniting scientists, healthcare professionals, patient organisations, and other stakeholders to achieve a better understanding of the bidirectional relationship and causal links between acute respiratory infections and non-communicable diseases.
• Early Career Scientists' Network (ECaS)

Named customers2 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

25 partnerships are on record, tiered core and minor.

• Asia Pacific Alliance for the Control of Influenza (APACI)coreStrategic or Co-development PartnerAPACI is a coalition partner working collaboratively with ESWI to advance the important work to reduce the burden of major acute respiratory virus infections. APACI focuses on the Asia Pacific region, complementing ESWI's European mandate.
• Coalition for Life Course Immunisation (CLCI)coreStrategic or Co-development PartnerCLCI is a coalition partner of ESWI, collaborating on life course immunisation initiatives. ESWI hosts CLCI board members in its conference sessions, such as the 'Life Course Immunisation: A Seamless Approach to Protection Across All Ages' session.
• European Academy of Paediatrics (EAP)coreStrategic or Co-development PartnerEAP is a coalition partner, collaborating on paediatric aspects of respiratory virus prevention and vaccination advocacy.
• European Heart Network (EHN)coreStrategic or Co-development PartnerEHN is a coalition partner, focusing on the intersection of cardiovascular diseases and respiratory virus infections. EHN's involvement relates to the Interdisciplinary Disease Collaboration on Respiratory Infections and NCDs.
• European Interdisciplinary Council on Ageing (EICA)coreStrategic or Co-development PartnerEICA is a coalition partner addressing the needs of older adults in the context of influenza and respiratory virus prevention.
• European Medical Association (EMA)minorStrategic or Co-development PartnerEMA is a coalition partner of ESWI, collaborating on medical education and respiratory virus awareness.
• European Respiratory Society (ERS)coreStrategic or Co-development PartnerERS is a major coalition partner, providing scientific and clinical expertise in respiratory diseases. ERS collaborates with ESWI on conferences and educational content related to respiratory infections.
• European Society of Clinical Microbiology and Infectious Diseases (ESCMID)coreStrategic or Co-development PartnerESCMID is a coalition partner, contributing expertise in clinical microbiology and infectious diseases to ESWI's activities.
• European Society for Clinical Virology (ESCV)coreStrategic or Co-development PartnerESCV is a coalition partner collaborating on clinical virology aspects of influenza and respiratory viruses.
• European Specialist Nurses Organisation (ESNO)coreStrategic or Co-development PartnerESNO is a coalition partner focused on promoting and representing specialist nurses' interests in a European context. ESWI collaborates with ESNO on vaccination and infection control projects.
• European Society for Paediatric Infectious Diseases (ESPID)coreStrategic or Co-development PartnerESPID is a coalition partner contributing expertise in paediatric infectious diseases and vaccination for children.
• European Union Geriatric Medicine Society (EUGMS)coreStrategic or Co-development PartnerEUGMS is a coalition partner addressing respiratory virus prevention and vaccination for older adults and geriatric populations.
• Foundation of European Nurses in Diabetes (FEND)coreStrategic or Co-development PartnerFEND is a coalition partner focusing on the intersection of diabetes and respiratory virus infections, particularly influenza vaccination for people with diabetes.
• International Diabetes Federation-Europe (IDF-Europe)coreStrategic or Co-development PartnerIDF-Europe is a coalition partner, collaborating on awareness and vaccination advocacy for people with diabetes in the context of respiratory virus infections.
• International Federation on AgeingcoreStrategic or Co-development PartnerIFA is a coalition partner with general consultative status at the United Nations and a non-State Actor with WHO. IFA represents over 75 million older people and collaborates with ESWI on age-related respiratory virus policies.
• Immunisation Coalition (Australia)minorStrategic or Co-development PartnerThe Immunisation Coalition from Australia is a global coalition partner of ESWI, extending its reach beyond Europe.
• International Society of Travel Medicine (ISTM)minorStrategic or Co-development PartnerISTM is a coalition partner addressing travel medicine aspects of respiratory virus prevention and vaccination.
• Middle East, Eurasia And Africa Influenza Stakeholders Network (ME'NA-ISN)minorStrategic or Co-development PartnerME'NA-ISN is a coalition partner extending ESWI's network to the Middle East, Eurasia, and Africa for influenza surveillance and advocacy.
• Pharmaceutical Group to the EU (PGEU)coreStrategic or Co-development PartnerPGEU represents European community pharmacists and is a coalition partner, working with ESWI on vaccination awareness and public health communication.
• Resilience Action Network International (RANI)minorStrategic or Co-development PartnerRANI is a coalition partner of ESWI, contributing to resilience and public health preparedness initiatives.
• Ready2RespondcoreStrategic or Co-development PartnerReady2Respond is a coalition partner focused on pandemic and emergency preparedness for respiratory virus infections.
• US National Adult and Influenza Vaccine SummitcoreStrategic or Co-development PartnerThe US National Adult and Influenza Vaccine Summit is a coalition partner, providing a transatlantic link for collaboration on influenza and adult vaccination.
• Vaccines EuropecoreStrategic or Co-development PartnerVaccines Europe is a coalition partner representing vaccine manufacturers in Europe, collaborating with ESWI on vaccination advocacy and education.
• Vaccine Safety Initiative (ViVi)coreStrategic or Co-development PartnerViVi (Vienna Vaccine Safety Initiative) is a coalition partner, focused on vaccine safety communication, monitoring, and prevention of infectious diseases. ViVI is involved in EU-funded projects to improve vaccine uptake.
• World Organization of Family Physicians (WONCA)coreStrategic or Co-development PartnerWONCA is a coalition partner representing family physicians globally, working with ESWI on respiratory virus awareness and vaccination in primary care settings.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• European Respiratory Society (ERS): ERS is a major pan-European scientific society covering all respiratory diseases, including influenza and RSV. It is a core ESWI coalition partner and a much larger organisation by membership and budget, but it lacks ESWI's specific science-policy interface focus on acute respiratory viruses.
• American Thoracic Society (ATS): ATS is a large US-based medical society for respiratory and critical care professionals. Its scientific conferences and clinical guidelines overlap substantially with ESWI's respiratory virus scope, although ATS is broader in focus and significantly larger in membership.
• European Society of Clinical Microbiology and Infectious Diseases (ESCMID): ESCMID is the leading European society for clinical microbiology and infectious diseases. It is a core ESWI coalition partner and a much larger incumbent, hosting its own congress and education platforms that overlap with ESWI's clinical infectious disease agenda.
• Infectious Diseases Society of America (IDSA): IDSA is the largest US-based professional society for infectious disease physicians, with comparable convening, guideline, and advocacy functions around influenza, RSV, and COVID-19. It represents the natural North American counterpart to ESWI's European focus.

Emerging players

• Sabin Vaccine Institute: Sabin Vaccine Institute is a US-based nonprofit focused on vaccine advocacy, immunisation education, and policy. It runs comparable educational programming and policy convenings related to influenza and respiratory virus vaccination, with a more global health and policy framing than ESWI.
• Ready2Respond: Ready2Respond is a coalition focused on pandemic and emergency preparedness for respiratory virus infections and is a core ESWI partner. It is smaller and more narrowly scoped than ESWI, but operates an overlapping advocacy and education model that could emerge as a competing convener.

Direct peers

• Asia Pacific Alliance for the Control of Influenza (APACI): APACI is a regional scientific coalition with a mandate essentially identical to ESWI but focused on the Asia Pacific region. It is listed as an ESWI coalition partner, and both organisations pursue stakeholder communication on influenza burden reduction, making them the most directly comparable peer.
• Immunisation Coalition (Australia): Immunisation Coalition is an Australian not-for-profit focused on vaccination advocacy and education, listed as an ESWI global coalition partner. It operates a comparable model of educational content, expert networks, and stakeholder convening but at a national/regional scale.
• Coalition for Life Course Immunisation (CLCI): CLCI is a European coalition advocating for life-course immunisation and is a core ESWI coalition partner. It mirrors ESWI's convening-and-advocacy model but with a broader vaccination mandate rather than disease-specific to influenza.
• International Society for Vaccines (ISV): ISV is a global scientific organisation convening vaccine researchers across diseases including influenza. It hosts vaccine-focused congresses and educational content analogous to ESWI's conferences and Education Hub, making it a structurally similar scientific working group.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/eswi

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about European Scientific Working group on Influenza